Asia Pacific Medtech Boom: $132 Billion Demand by 2030 Faces Scale-Up Barriers
Asia Pacific medtech demand is projected to hit $132 billion by 2030 according to a new Bain report.
The region is growing at 6.9 percent annually outpacing the global average.
Key Barriers Limiting Global Scale
Only a handful of companies have successfully launched competitive products worldwide.
Funding remains limited with just $2.2 billion raised in early rounds during 2025.
Talent shortages in regulatory and clinical expertise hinder progress on international approvals.
Intellectual property gaps and weak commercialization infrastructure add further obstacles.
Why This Growth Matters for Everyday Health
Ageing populations and rising chronic diseases are fueling the surge across the region.
Successful scaling could bring more affordable innovations to patients everywhere.
Countries like Singapore are emerging as hubs for turning research into viable products.
Strategic investments over the next two years will shape whether Asia Pacific becomes a major exporter of medical technology.
This shift promises broader access to advanced care and stronger competition in the global market.
